Schrodinger H-1B Visa Sponsorship 2026
Pharma & biotech Β· H-1B sponsor Β· FY2017β2026
π’ New York, NY HQπ schrodinger.com
Does Schrodinger sponsor H-1B visas and green cards?
Yes. Schrodinger has filed 198 H-1B LCAs and 24 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025β2026 Schrodinger filed 61 H-1B LCAs at a median base salary of $145,500, about 19% above the national H-1B median of $121,966 for the same period, and 4 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 29 | $148k |
| FY2025 | 32 | $145k |
| FY2024 | 14 | $135k |
| FY2023 | 20 | $135k |
| FY2022 | 22 | $126k |
| FY2021 | 25 | $120k |
| FY2020 | 17 | $110k |
| FY2019 | 15 | $110k |
| FY2018 | 9 | $130k |
| FY2017 | 15 | $103k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year β
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 2 | $154k |
| FY2025 | 2 | $144k |
| FY2024 | 3 | $120k |
| FY2023 | 1 | $67k |
| FY2022 | 1 | $144k |
| FY2021 | 7 | $110k |
| FY2020 | 3 | $110k |
| FY2019 | 1 | $124k |
| FY2018 | 2 | $132k |
| FY2017 | 2 | $123k |
Green-card route and outcomes
Worker backgrounds Β· FY2017β2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 3
- US patents
- Published, not yet granted
- 1
- applications
- Most recent grant
- January 2, 2018
- Top area
- Computational chemistry; chemoinformatics3
Pay against the local market
Schrodingerβs 10 most-filed occupations and metros. Its median base salary is 122% of the local BLS median for the same work.
| Occupation | Metro | Filings | Schrodinger pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | New York, NY | 61 | $147,367 | $100,611 | 146% |
| Software Developers | New York, NY | 35 | $129,106 | $134,375 | 96% |
| Biochemists and Biophysicists | New York, NY | 20 | $134,260 | $105,675 | 127% |
| Chemists | New York, NY | 8 | $126,688 | $86,064 | 147% |
| Biological Scientists, All Other | San Diego, CA | 8 | $132,688 | $104,938 | 126% |
| Network and Computer Systems Administrators | New York, NY | 6 | $133,253 | $109,752 | 121% |
| Biological Scientists, All Other | Portland, OR | 6 | $90,875 | $91,635 | 99% |
| Biological Scientists, All Other | Boston, MA | 5 | $134,640 | $103,120 | 131% |
| Computer Occupations, All Other | Portland, OR | 3 | $83,333 | $85,374 | 98% |
| Software Quality Assurance Analysts and Testers | New York, NY | 3 | $122,033 | $121,520 | 100% |
About Schrodinger
Schrodinger is a pharma & biotech company based in New York City. It was founded in 1990. It is listed on Nasdaq as SDGR.
- Legal name
- Schrodinger, Inc.
- Listed
- Nasdaq: SDGR
- Incorporated in
- Delaware
- Headquarters
- 1540 Broadway, New York, NY 10036
- Industry
- Pharma & biotech
- Employees (US, est)
- 652 (2024)
- Revenue FY2025
- $256M +23% from $208M
- Net income FY2025
- $-103M +45% from $-187M
- R&D FY2025
- $173M (68% of revenue)
Schrodinger pays a median H-1B base of $130,000 across FY2017β2026, about 20% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Schrodinger
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Bioinfo Systems | 343 | 24 | $87k | 3 | 13% |
| Climate | 307 | 25 | $157k | 2 | 86% |
| Alexion | 301 | 85 | $145k | 36 | 44% |
| Schrodinger | 198 | 61 | $146k | 33 | 31% |
| Aurobindo Pharma | 193 | 30 | $99k | 12 | 40% |
| Genscript | 188 | 71 | $88k | 47 | 13% |
| APPCO Pharma | 186 | 10 | $67k | 1 | β |
